The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis

---

Copy For Citation

PAYDAŞ S., KURT C., TAŞKAPAN H., BALAL M., SERTDEMİR Y., Pembegul I.

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.41, no.1, pp.145-152, 2009 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 41 Issue: 1
• Publication Date: 2009
• Doi Number: 10.1007/s11255-008-9454-4
• Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.145-152
• Çukurova University Affiliated: Yes

Abstract

Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].